Arista Networks has lagged the broader market over the past year, yet analysts remain strongly bullish, reflecting high confidence in the company’s long-term growth
Latest News
First Solar Stock Outlook: Is Wall Street Bullish or Bearish?
First Solar, Inc. (FSLR) is a leading American manufacturer of thin-film photovoltaic solar modules using cadmium telluride (CdTe) technology. Headquartered in Tempe, Arizona, the
Prediction: This Cryptocurrency Could Soar 80% in 2026
Hyperliquid is one of the top-performing cryptocurrencies of 2026, up more than 30% in just one month. Trading in crypto perpetual futures propelled Hyperliquid
Bitcoin’s Reclaims $70,000, But Analysts Aren’t Too Sure Of A Relief-Rally
Crypto markets rebounded sharply after Thursday’s washout, driven by short liquidations, lifting Bitcoin above $70,000 and triggering a broad altcoin rally amid improving retail
3 High-Yield Dividend Stocks Perfect For Those 60+ Years
Financial objectives and risk tolerance will, as you’re probably well aware, change as individuals progress through the various stages of life. Investing at 60+
7 Best Drone Stocks to Buy for 2026
Red Cat expects fourth-quarter revenues to range from $24 million to $26.5 million, representing a roughly 1,831% increase from the $1.3 million recorded in
Cathie Wood Makes $17 Million Crypto Shift — ARK ETFs Rotate From Coinbase To Bullish
Cathie Wood’s ARK Invest is reshuffling its crypto exposure across flagship ETFs, snapping up shares of crypto exchange operator Bullish BLSH, while trimming holdings
PYPL stock has shed 30% over past 10 sessions – so why is retail still bullish?
The sharpest drop came after its disappointing fourth-quarter results on February 3, when the shares closed 20% lower. ・Users see the stock as undervalued
AI bubble watch: Spooked market sparks $1 trillion Friday tech sell-off
The immediate spark for the Friday sell-off was the Amazon fourth-quarter earnings report. The e-commerce giant projected that its capital expenditures would reach $200
This pharma stock with earnings seen soaring 1,854% forms bullish base
This pharma stock projected to post stout earnings growth is forming a bullish chart pattern despite the stock market carnage.